Raises FY Revenue Outlook to $1.93B-$1.945B
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy CVSA?
Consensus is $7.91. Raises FY revenue view to $1.93B-$1.945B from $1.9B-$1.94B, consensus $1.92B.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CVSA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CVSA
Wall Street analysts forecast CVSA stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 133.730
Low
Averages
High
Current: 133.730
Low
Averages
High
About CVSA
Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
MNDY Surges on AI-Driven Efficiency Gain
- Earnings Beat: monday.com (MNDY) reported Q1 revenue of $351.3 million, a 24% year-over-year increase that exceeded analyst expectations, showcasing the company's strong performance and growth potential in the market.
- Strategic Shift: Leadership highlighted the transition to consumption-based pricing and the successful rollout of its AI Work Platform as key drivers, which not only enhanced customer satisfaction but also strengthened competitive positioning in the market.
- Operational Leverage: CFO Eliran Glazer noted that internal AI productivity gains allow the company to scale revenue without increasing headcount, indicating a higher operational efficiency achieved in a complex environment.
- Strong Cash Flow: The firm generated over $102 million in adjusted free cash flow, providing substantial capital to further invest in autonomous AI agents, thereby enhancing the sustainability of future growth.
See More
Covista Reports Strong Quarterly Results and Raises Annual Guidance
- Student Enrollment Growth: Covista's total student enrollment reached 100,585 for the quarter, reflecting a 6.8% year-over-year increase, surpassing expectations and indicating the effectiveness of the company's operational model, with Q4 expected to maintain this growth momentum into the fall enrollment cycle.
- Revenue Guidance Increase: The company raised its FY26 revenue guidance from a range of $1.9 billion to $1.94 billion to a new range of $1.93 billion to $1.945 billion, projecting nearly 8% to 9% year-over-year growth, reflecting optimistic expectations for future market demand.
- Adjusted EPS Improvement: Covista increased its adjusted earnings per share guidance from a previous range of $7.80 to $8.00 to a new range of $7.95 to $8.15, demonstrating enhanced profitability and boosting investor confidence.
- Q3 Performance Exceeds Expectations: The company reported third-quarter revenue of $487 million, a 4.5% year-over-year increase, beating market estimates by $13.01 million, with adjusted EPS of $1.98 exceeding consensus by $0.26, showcasing strong performance in a competitive education market.
See More
Covista Q3 Earnings: Rebranding and Growth Insights
- Strong Performance: Covista reported a 4.5% year-over-year revenue increase to $487 million in Q3, with an adjusted growth of 8.4% when excluding academic calendar shifts, highlighting robust demand and adaptability in the healthcare sector.
- Enrollment Milestone: The company surpassed 100,000 registered students, with Walden achieving a 12.3% increase to over 54,000 students, indicating the effectiveness of its educational model and growing market appeal.
- Guidance Upgrade: CFO Phelan raised full-year revenue guidance to a range of $1.93 billion to $1.945 billion and adjusted EPS guidance to $7.95 to $8.15, reflecting strong confidence in future growth prospects.
- Ongoing Strategic Investments: The company plans to continue strategic investments in Q4, including the development of six new campuses and a new brand campaign, aimed at further enhancing market share and brand influence.
See More
Covista Reports Significant Growth in Q3 Performance
- Total Enrollment Growth: Covista's total student enrollment reached 100,585, marking a 6.8% year-over-year increase, with both Chamberlain and Walden universities achieving record highs, indicating strong momentum in the higher education sector.
- Significant Revenue Increase: The company reported third-quarter revenue of $487 million, up 4.5% year-over-year, and an 8.4% increase when adjusted for Walden's one-week academic shift, reflecting robust performance and improved profitability in the education market.
- Optimized Capital Allocation: In the third quarter, Covista repurchased $66 million in shares and successfully refinanced its debt into a $510 million Term Loan B, extending maturity to 2033, resulting in a net leverage ratio of 0.7x, enhancing financial flexibility.
- Positive Future Outlook: Covista raised its fiscal year 2026 revenue guidance to $1.93 billion to $1.945 billion, anticipating 8% to 9% year-over-year growth, while also increasing adjusted earnings per share expectations to $7.95 to $8.15, demonstrating confidence in future growth prospects.
See More
Covista Launches Healthcare AI Credentials and Future Classroom Development
- Healthcare AI Credentials Live: Covista's healthcare AI credentials, launched in collaboration with Google Cloud, are now available across five institutions, attracting over 3,400 students in the first week, indicating a strong demand for AI fluency in the healthcare sector, which is expected to enhance graduates' competitiveness in the job market.
- Future Classroom Development: Covista is developing an AI-powered future classroom aimed at enhancing educational quality through personalized learning experiences, integrating tools like LearnLM, Gemini, and NotebookLM, with a pilot expected later this year to transform educational methodologies.
- Advisory Council of Industry Leaders: Covista has established the Healthcare AI Readiness Council, bringing together healthcare executives and technology innovators to guide curriculum design, ensuring that AI innovations are closely aligned with clinical practice, thereby producing graduates equipped with essential AI skills.
- Flexible Curriculum Design: The newly launched AI certificate programs are accessible not only to current students but also to alumni and healthcare professionals, with flexible coursework tailored to the schedules of working clinicians, helping them master AI applications in clinical settings to improve patient care quality.
See More
Insider Buying Analysis: Alpha Metallurgical and Covista
- Insider Trading Activity: Director Kenneth S. Courtis of Alpha Metallurgical Resources purchased 25,000 shares of AMR on Monday at $176.23 each, totaling an investment of $4.41 million, indicating confidence in the company's future performance.
- Return on Investment: At today's trading high, Courtis's investment saw an 11.9% return, with AMR reaching a peak price of $197.21, reflecting a positive market response to the stock.
- Historical Purchase Record: Over the past 12 months, Courtis has made four additional purchases of AMR shares, totaling $30.74 million at an average cost of $161.79 per share, demonstrating his sustained optimism about the company's long-term prospects.
- Covista Trading Activity: Director Michael W. Malafronte of Covista bought 36,036 shares on Wednesday at $100.88 each, amounting to a total investment of $3.64 million, with the stock currently up 0.8%, indicating market approval of his investment.
See More
MNDY Surges on AI-Driven Efficiency Gain
- Earnings Beat: monday.com (MNDY) reported Q1 revenue of $351.3 million, a 24% year-over-year increase that exceeded analyst expectations, showcasing the company's strong performance and growth potential in the market.
- Strategic Shift: Leadership highlighted the transition to consumption-based pricing and the successful rollout of its AI Work Platform as key drivers, which not only enhanced customer satisfaction but also strengthened competitive positioning in the market.
- Operational Leverage: CFO Eliran Glazer noted that internal AI productivity gains allow the company to scale revenue without increasing headcount, indicating a higher operational efficiency achieved in a complex environment.
- Strong Cash Flow: The firm generated over $102 million in adjusted free cash flow, providing substantial capital to further invest in autonomous AI agents, thereby enhancing the sustainability of future growth.
See More
Covista Reports Strong Quarterly Results and Raises Annual Guidance
- Student Enrollment Growth: Covista's total student enrollment reached 100,585 for the quarter, reflecting a 6.8% year-over-year increase, surpassing expectations and indicating the effectiveness of the company's operational model, with Q4 expected to maintain this growth momentum into the fall enrollment cycle.
- Revenue Guidance Increase: The company raised its FY26 revenue guidance from a range of $1.9 billion to $1.94 billion to a new range of $1.93 billion to $1.945 billion, projecting nearly 8% to 9% year-over-year growth, reflecting optimistic expectations for future market demand.
- Adjusted EPS Improvement: Covista increased its adjusted earnings per share guidance from a previous range of $7.80 to $8.00 to a new range of $7.95 to $8.15, demonstrating enhanced profitability and boosting investor confidence.
- Q3 Performance Exceeds Expectations: The company reported third-quarter revenue of $487 million, a 4.5% year-over-year increase, beating market estimates by $13.01 million, with adjusted EPS of $1.98 exceeding consensus by $0.26, showcasing strong performance in a competitive education market.
See More
Covista Q3 Earnings: Rebranding and Growth Insights
- Strong Performance: Covista reported a 4.5% year-over-year revenue increase to $487 million in Q3, with an adjusted growth of 8.4% when excluding academic calendar shifts, highlighting robust demand and adaptability in the healthcare sector.
- Enrollment Milestone: The company surpassed 100,000 registered students, with Walden achieving a 12.3% increase to over 54,000 students, indicating the effectiveness of its educational model and growing market appeal.
- Guidance Upgrade: CFO Phelan raised full-year revenue guidance to a range of $1.93 billion to $1.945 billion and adjusted EPS guidance to $7.95 to $8.15, reflecting strong confidence in future growth prospects.
- Ongoing Strategic Investments: The company plans to continue strategic investments in Q4, including the development of six new campuses and a new brand campaign, aimed at further enhancing market share and brand influence.
See More
Covista Reports Significant Growth in Q3 Performance
- Total Enrollment Growth: Covista's total student enrollment reached 100,585, marking a 6.8% year-over-year increase, with both Chamberlain and Walden universities achieving record highs, indicating strong momentum in the higher education sector.
- Significant Revenue Increase: The company reported third-quarter revenue of $487 million, up 4.5% year-over-year, and an 8.4% increase when adjusted for Walden's one-week academic shift, reflecting robust performance and improved profitability in the education market.
- Optimized Capital Allocation: In the third quarter, Covista repurchased $66 million in shares and successfully refinanced its debt into a $510 million Term Loan B, extending maturity to 2033, resulting in a net leverage ratio of 0.7x, enhancing financial flexibility.
- Positive Future Outlook: Covista raised its fiscal year 2026 revenue guidance to $1.93 billion to $1.945 billion, anticipating 8% to 9% year-over-year growth, while also increasing adjusted earnings per share expectations to $7.95 to $8.15, demonstrating confidence in future growth prospects.
See More
Covista Launches Healthcare AI Credentials and Future Classroom Development
- Healthcare AI Credentials Live: Covista's healthcare AI credentials, launched in collaboration with Google Cloud, are now available across five institutions, attracting over 3,400 students in the first week, indicating a strong demand for AI fluency in the healthcare sector, which is expected to enhance graduates' competitiveness in the job market.
- Future Classroom Development: Covista is developing an AI-powered future classroom aimed at enhancing educational quality through personalized learning experiences, integrating tools like LearnLM, Gemini, and NotebookLM, with a pilot expected later this year to transform educational methodologies.
- Advisory Council of Industry Leaders: Covista has established the Healthcare AI Readiness Council, bringing together healthcare executives and technology innovators to guide curriculum design, ensuring that AI innovations are closely aligned with clinical practice, thereby producing graduates equipped with essential AI skills.
- Flexible Curriculum Design: The newly launched AI certificate programs are accessible not only to current students but also to alumni and healthcare professionals, with flexible coursework tailored to the schedules of working clinicians, helping them master AI applications in clinical settings to improve patient care quality.
See More
Insider Buying Analysis: Alpha Metallurgical and Covista
- Insider Trading Activity: Director Kenneth S. Courtis of Alpha Metallurgical Resources purchased 25,000 shares of AMR on Monday at $176.23 each, totaling an investment of $4.41 million, indicating confidence in the company's future performance.
- Return on Investment: At today's trading high, Courtis's investment saw an 11.9% return, with AMR reaching a peak price of $197.21, reflecting a positive market response to the stock.
- Historical Purchase Record: Over the past 12 months, Courtis has made four additional purchases of AMR shares, totaling $30.74 million at an average cost of $161.79 per share, demonstrating his sustained optimism about the company's long-term prospects.
- Covista Trading Activity: Director Michael W. Malafronte of Covista bought 36,036 shares on Wednesday at $100.88 each, amounting to a total investment of $3.64 million, with the stock currently up 0.8%, indicating market approval of his investment.
See More
